Insights at ACR 2021: JAKs in Spondyloarthritis
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
11 Des 202130min
Insights at ACR 2021: COVID-19 Vaccination and Rituximab
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
10 Des 202131min
Insights at ACR 2021: Impact of COVID-19 on Practice
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
9 Des 202139min
Insights at ACR 2021: COVID Vaccinations
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
7 Des 202140min
Author Interview: Professor Atul Deodhar
Professor Atul Deodhar, professor of medicine at Oregon Health & Science University. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Pro...
6 Des 202124min
Discussing Rheumatology: Risk of HZ with UPA, and JAKs in SpA
Prof Iain McInnes reviews two papers this month, and discusses the increased risk of HZ infection with upadacitinib, as well as the role of the JAK-STAT pathway in SpA pathenogenesis. Keep-up to date ...
6 Des 20218min
Author Interview: Professor Roy Fleischmann
Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center. Join Professor Peter Nash as he interviews authors of recent notable papers in rheuma...
18 Nov 202128min
ACR 2021: Day 4 Highlights
Grace Wright presents the Day 4 highlights of the key abstracts and posters presented at ACR 2021.
9 Nov 202126min
